|GLA-SE, a synthetic toll-like receptor 4 agonist, enhances T-cell responses to influenza vaccine in older adults|
H Behzad, ALW Huckriede, L Haynes, B Gentleman, K Coyle, JC Wilschut, ...
Journal of Infectious Diseases 205 (3), 466-473, 2012
|Aldehyde dehydrogenase 1A3 influences breast cancer progression via differential retinoic acid signaling|
P Marcato, CA Dean, RZ Liu, KM Coyle, M Bydoun, M Wallace, ...
Molecular oncology 9 (1), 17-31, 2015
|Core needle biopsy of breast cancer tumors increases distant metastases in a mouse model|
EG Mathenge, CA Dean, D Clements, A Vaghar-Kashani, S Photopoulos, ...
Neoplasia 16 (11), 950-960, 2014
|Hide-and-seek: the interplay between cancer stem cells and the immune system|
M Sultan, KM Coyle, D Vidovic, ML Thomas, S Gujar, P Marcato
Carcinogenesis 38 (2), 107-118, 2017
|Chemoresistance in cancer stem cells and strategies to overcome resistance|
ML Thomas, KM Coyle, M Sultan, A Vaghar-Kashani, P Marcato
Chemotherapy 3 (125), 2, 2014
|Genetic mutations and epigenetic modifications: driving cancer and informing precision medicine|
KM Coyle, JE Boudreau, P Marcato
BioMed Research International 2017, 2017
|Citral reduces breast tumor growth by inhibiting the cancer stem cell marker ALDH1A3|
ML Thomas, R De Antueno, KM Coyle, M Sultan, BM Cruickshank, ...
Molecular oncology 10 (9), 1485-1496, 2016
|Phthalate esters affect maturation and function of primate testis tissue ectopically grafted in mice|
JR Rodriguez-Sosa, A Bondareva, L Tang, GF Avelar, KM Coyle, ...
Molecular and cellular endocrinology 398 (1-2), 89-100, 2014
|ALDH1A3-regulated long non-coding RNA NRAD1 is a potential novel target for triple-negative breast tumors and cancer stem cells|
D Vidovic, TT Huynh, P Konda, C Dean, BM Cruickshank, M Sultan, ...
Cell Death & Differentiation 27 (1), 363-378, 2020
|Epigenetic Silencing of TAP1 in Aldefluor+ Breast Cancer Stem Cells Contributes to Their Enhanced Immune Evasion|
M Sultan, D Vidovic, AS Paine, TT Huynh, KM Coyle, ML Thomas, ...
Stem Cells 36 (5), 641-654, 2018
|Breast cancer subtype dictates DNA methylation and ALDH1A3-mediated expression of tumor suppressor RARRES1|
KM Coyle, JP Murphy, D Vidovic, A Vaghar-Kashani, CA Dean, M Sultan, ...
Oncotarget 7 (28), 44096, 2016
|Newly recruited CD11b+, GR-1+, Ly6Chigh myeloid cells augment tumor-associated immunosuppression immediately following the therapeutic administration of oncolytic reovirus|
DR Clements, AM Sterea, Y Kim, E Helson, CA Dean, A Nunokawa, ...
The Journal of Immunology 194 (9), 4397-4412, 2015
|Retinoid signaling in cancer and its promise for therapy|
KM Coyle, M Sultan, ML Thomas, A Vaghar-Kashani, P Marcato
J Carcinog Mutagen S 7, 16-18, 2013
|DNA methylation predicts the response of triple-negative breast cancers to all-trans retinoic acid|
KM Coyle, CA Dean, ML Thomas, D Vidovic, CA Giacomantonio, L Helyer, ...
Cancers 10 (11), 397, 2018
|Profiling of the transcriptional response to all-trans retinoic acid in breast cancer cells reveals RARE-independent mechanisms of gene expression|
KM Coyle, S Maxwell, ML Thomas, P Marcato
Scientific reports 7 (1), 1-13, 2017
|Phloridzin docosahexaenoate, a novel fatty acid ester of a plant polyphenol, inhibits mammary carcinoma cell metastasis|
W Fernando, K Coyle, P Marcato, HPV Rupasinghe, DW Hoskin
Cancer letters 465, 68-81, 2019
|Coding and non-coding drivers of mantle cell lymphoma identified through exome and genome sequencing|
P Pararajalingam, KM Coyle, S Arthur, N Thomas, M Alcaide, B Meissner, ...
|Decitabine response in breast cancer requires efficient drug processing and is not limited by multidrug resistance|
ML Dahn, BM Cruickshank, AJ Jackson, C Dean, RW Holloway, SR Hall, ...
Molecular Cancer Therapeutics 19 (5), 1110-1122, 2020
|Genetic and evolutionary patterns of treatment resistance in relapsed B-cell lymphoma|
CK Rushton, SE Arthur, M Alcaide, M Cheung, A Jiang, KM Coyle, ...
Blood advances 4 (13), 2886-2898, 2020
|Phloridzin docosahexaenoate (PZ-DHA) inhibits breast cancer cell invasion and angiogenesis|
W Fernando, E MacLean, K Coyle, P Marcato, DW Hoskin, ...
Cancer Research 77 (13 Supplement), 910-910, 2017